ici 118551 and Retinopathy of Prematurity

ici 118551 has been researched along with Retinopathy of Prematurity in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagnoli, P; Cupisti, E; Filippi, L; Fiorini, P; Martini, D; Mei, S; Monte, MD; Ristori, C1

Other Studies

1 other study(ies) available for ici 118551 and Retinopathy of Prematurity

ArticleYear
Antiangiogenic effects of β2 -adrenergic receptor blockade in a mouse model of oxygen-induced retinopathy.
    Journal of neurochemistry, 2011, Volume: 119, Issue:6

    Topics: Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Animals; Animals, Newborn; Atenolol; Cyclic AMP-Dependent Protein Kinases; Disease Models, Animal; Dose-Response Relationship, Drug; Electroretinography; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation, Developmental; Humans; Infant, Newborn; Insulin-Like Growth Factor I; Male; Mice; Mice, Inbred C57BL; Organ Culture Techniques; Oxygen; Platelet Endothelial Cell Adhesion Molecule-1; Propanolamines; Receptors, Adrenergic, beta-2; Retinal Neovascularization; Retinopathy of Prematurity; RNA, Messenger; RNA, Small Interfering; Statistics, Nonparametric; Transfection; Vascular Endothelial Growth Factor A

2011